Tirofiban in emergency conditions

Affiliations

¹ Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy in Warsaw, Warsaw, Poland; Maria Sklodowska-Curie Białystok Oncology Centre, Białystok, Poland; Polish Society of Disaster Medicine, Warsaw, Poland. Electronic address: lukasz.szarpak@gmail.com.
² Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA.
³ Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
⁴ 1st Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
⁵ 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Review

Lukasz Szarpak et al. Am J Emerg Med. 2022 Jan.

. 2022 Jan:51:422-423.

doi: 10.1016/j.ajem.2021.03.063. Epub 2021 Mar 24.

¹ Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy in Warsaw, Warsaw, Poland; Maria Sklodowska-Curie Białystok Oncology Centre, Białystok, Poland; Polish Society of Disaster Medicine, Warsaw, Poland. Electronic address: lukasz.szarpak@gmail.com.
² Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA.
³ Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
⁴ 1st Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
⁵ 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

No abstract available

Conflict of interest statement

Declaration of competing interest None.